Anti-infection
-
BA1834 ElebsiranSummary: An siRNA against hepatitis B virus and hepatitis D virus (HDV) infection. - BA1837 HBV-IN-4Summary: HBV-IN-4, a phthalazinone derivative, is a potent replication inhibitor with oral activity.
- BA1845 RO6889678Summary: RO6889678 is a potent inhibitor of the coat structure with a complex absorption, distribution, metabolism and excretion (ADME) profile.
- BA1852 NIM811Summary: NIM811 ((Melle-4)cyclosporin; SDZNIM811) is an orally active dual inhibitor of mitochondrial osmotic transition and procyclosporin.
- BA1855 AlisporivirSummary: Alisporivir (Debio-025) is a procyclin inhibitor.
- BA1858 GSK-A1Summary: GSK-A1 is a selective type III phosphatidylinositol 4-kinase PI4KA inhibitor.
- BA1859 PeretinoinSummary: Peretinoin is an orally administered non-cyclic retinoid with a vitamin A-like structure that targets retinoid nuclear receptors, such as and ...
- BA1861 OglufanideSummary: Oglufanide (H-Glu-Trp-OH) is a dipeptide immunomodulator isolated from calf thymus that inhibits vascular endothelial growth factor.
- BA1863 ITX5061Summary: The ITX5061 is a Type II inhibitor.
- BA1864 R-1479Summary: R-1479 (4'-Azidocytidine) is a nucleoside analog that is a specific RNA-dependent RNA polymerase inhibitor.